Search

Your search keyword '"Zoller, Thomas"' showing total 286 results

Search Constraints

Start Over You searched for: Author "Zoller, Thomas" Remove constraint Author: "Zoller, Thomas"
286 results on '"Zoller, Thomas"'

Search Results

3. Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance

4. DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance

5. Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)

6. Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer

7. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

8. Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study

9. Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL

10. Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study

11. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics

13. Functional limitations 12 months after SARS-CoV-2 infection correlate with initial disease severity: An observational study of cardiopulmonary exercise capacity testing in COVID-19 convalescents

14. Author Correction: A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity

16. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity

19. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

20. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months

21. American Cutaneous Leishmaniasis: Imported cases in Berlin 2000–2023.

22. BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma

23. Use of a Handheld Ultrasonographic Device to Identify Heart Failure and Pulmonary Disease in Rural Africa

24. Design, Synthesis, and In Vitro and In Vivo Evaluation of Cereblon Binding Bruton’s Tyrosine Kinase (BTK) Degrader CD79b Targeted Antibody–Drug Conjugates

25. Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer

26. Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL

28. A time-resolved proteomic and prognostic map of COVID-19

30. Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)

31. Estimated Global Proportions of Individuals with Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021

32. Vitamin D and Osteogenesis Imperfecta in Pediatrics

33. Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19

34. Reinstating targeted protein degradation with DCAF1 PROTACs in CRBN PROTAC resistant settings

35. Intravenous Artesunate for Imported Severe Malaria in Children Treated in Four Tertiary Care Centers in Germany: A Retrospective Study

37. Knowledge, attitudes, behaviors, and serological status related to Chagas disease among Latin American migrants in Germany: A cross-sectional study in six German cities

38. Post-treatment haemolysis is common following oral artemisinin combination therapy of uncomplicated malaria in travellers

40. Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study

41. Understanding the widespread use of veterinary ivermectin for Chagas disease, underlying factors and implications for the COVID-19 pandemic: a convergent mixed-methods study

42. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021

43. Congenital Heart Disease: Growth Evaluation and Sport Activity in a Paediatric Population

44. Brief Research Report: Quantitative Analysis of Potential Coronary Microvascular Disease in Suspected Long-COVID Syndrome

45. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021

47. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics.

48. Effects of COVID‐19 lockdown on lifestyle behaviors in children with obesity: Longitudinal study update

50. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study

Catalog

Books, media, physical & digital resources